CCR5 entry inhibitor problems: no clear answers yet.
This new class of antiretrovirals is alive and well despite recent problems.
James
John S
JS
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D065100:CCR5 Receptor Antagonists; D006678:HIV / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans
D019380:Anti-HIV Agents; D065100:CCR5 Receptor Antagonists